Marketing

Company launching direct-to-consumer advertisements for HPV test

Published in Virus Weekly, April 5th, 2005

Digene Corp. (DIGE) announced that it is launching a direct-to-consumer advertising campaign to educate women about the link between human papilloma virus (HPV) and cervical cancer and the availability of a test for HPV.

The Digene HPV Test, also known as the DNAwithPap Test, is, according to the company, the only U.S. Food and Drug Administration (FDA)-approved test for high-risk types of HPV, which cause virtually all cases of cervical cancer. The test is approved for use along with the Pap test to screen women age 30 and older, the group most at risk of developing cervical cancer.

Underscoring the need for a direct-to-consumer educational...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Virus Weekly

Source: Virus Weekly (2005-04-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry